RELATED STUDY
Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug
Key Findings: This extensive analysis of the wide range of physiologic effects of different phytocannabinoid owing to the plant strains, chemical composition, metabolites, and endocannabinoid targets. The hundreds of other variations of the plant determine its medicinal potential as well as its adverse effect profile. Overall phytocannabinoids have been deemed safe and effective for many conditions, but the variations make predicting these effects more challenging.
Type of Study: Meta-analysis
Study Result: Positive
Study Location(s): Israel
Year of Pub: 2022
Cannabinoids Studied: Cannabichromene (CBC), Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC), Cannabinol (CBN), Cannabichromenic Acid (CBC-a), Cannabidiolic Acid (CBD-a), Cannabigerolic Acid (CBG-a), Tetrahydrocannabinolic Acid (THC-a), Anandamide (AEA), 2-Arachidonoyl Glycerol (2-AG), Tetrahydrocannabivarin (THCV), Cannabidivarin (CBDV), Cannabitriol (CBT)
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype I, Chemotype II, Chemotype III
Receptors Studied: CB1, CB2, GPCR
Route of Administration: Inhalation, Oral (Ingestion), Rectal, Sublingual/Oromucosal, Topical
Link to study
